16 August 2026 in SSRN Electronic Journal
The dura mater and arachnoid membrane are essential for maintaining central nervous system (CNS) homeostasis, and their disruption during neurosurgical procedures can lead to complications such as cerebrospinal fluid (CSF) leakage and infection. This study evaluated the efficacy and safety of a visible light–induced photocrosslinked gelatin hydrogel for dural reconstruction using a rat durotomy model. Animals were divided into three groups: control, collagen-based artificial dura (DuraGen®), and hydrogel treatment. Histological, immunohistochemical, Western blot, and real-time quantitative PCR analyses were performed at 1, 3, and 7 days postoperatively. The hydrogel demonstrated rapid in situ gelation and remained at the application site for up to 7 days before complete absorption by day 14. Histological analysis revealed effective formation of a membrane-like structure at the dural defect, with significantly greater thickness in the hydrogel group compared to the DuraGen® group at days 3 and 7. No cystic changes suggestive of pseudomeningocele were observed. Immunohistochemical staining and Western blot analysis showed no significant increase in microglial or astrocytic activation in the hydrogel group. Furthermore, inflammatory cytokine expression, including TNF-α, IL-1β, and IL-6, was not elevated compared to controls. These findings indicate that photocrosslinked gelatin hydrogel promotes early and robust dural repair without inducing significant inflammatory or cytotoxic responses. This material shows promise as a novel artificial dura substitute for neurosurgical applications.